HealthNotableConfirmedDeveloping
10.0
Brazil reports 118% increase in adult obesity prevalence since 2006
Valor Econômico·BR·1 day ago
The global prescription drug market is forecast to grow 62% by 2032, driven primarily by Eli Lilly's obesity treatments. These drugs are expected to comprise nearly 50% of the top ten best-selling therapies, followed by autoimmune disease treatments.